The United States generic injectables market is experiencing significant growth, driven by the rising demand for affordable and effective therapeutic options, especially as healthcare costs continue to increase. Valued at USD 15.07 billion in 2024, the market is poised to grow at a CAGR of 7.00% from 2025 to 2034, with expectations to reach a market value of USD 29.64 billion by 2034. In this...